Werkmeister J, Zaunders J, McCarthy W, Hersey P
Clin Exp Immunol. 1980 Sep;41(3):487-96.
We have previously shown that tumour cells may release soluble factors which inhibit the division of a variety of cells. These factors had marked immunosuppressive activity as shown by their ability to inhibit lymphocyte mitogenic responses to lectins, allogeneic lymphocytes and pokeweed mitogen-induced immunoglobulin production. It was postulated that these factors may play an important role in determining the outcome of tumour–host interactions in humans and be the source of immunosuppressive factors in the circulation of patients with cancer. In the present study, characterization of these mitogenic inhibitory factors released into the supernatants of cultured tumour cells was carried out by a number of sequential separation procedures involving affinity chromatography on wheat-germ lectin (WGL), gel filtration on PL-agarose and electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulphate (PAGE–SDS). The factors were identified throughout the separation procedure using inhibition of phytohaemagglutinin (PHA) stimulation of normal lymphocytes as an index of inhibitory function. By these techniques the inhibitory activity was shown to be associated with glycoproteins containing -acetyl-β-D-glucosamine (NAcGlu) and having molecular weights (mol. wt) of approximately 140,000 and over 200,000 daltons. A further small mol. wt peak of 70,000 daltons was observed on PAGE–SDS. pI values of the fractions were 7·4 and 4·2. The activity was destroyed by heating, low pH and repeated freeze-thawing but was resistant to proteolytic enzymes, deoxyribonuclease, ribonuclease and neuraminidase. The active fractions were not associated with proteolytic activity and the inhibition of mitogenic responses was irreversible in nature. These results form the basis of studies to detect this factor in biological fluids and further evaluate its role in the tumour–host relationship.
我们先前已经表明,肿瘤细胞可能释放抑制多种细胞分裂的可溶性因子。这些因子具有显著的免疫抑制活性,这可通过它们抑制淋巴细胞对凝集素、同种异体淋巴细胞的促有丝分裂反应以及商陆有丝分裂原诱导的免疫球蛋白产生的能力来证明。据推测,这些因子可能在决定人类肿瘤与宿主相互作用的结果中起重要作用,并且是癌症患者循环中免疫抑制因子的来源。在本研究中,通过一系列连续的分离程序对释放到培养肿瘤细胞上清液中的这些促有丝分裂抑制因子进行了表征,这些程序包括在麦胚凝集素(WGL)上进行亲和层析、在PL-琼脂糖上进行凝胶过滤以及在十二烷基硫酸钠存在下进行聚丙烯酰胺凝胶电泳(PAGE-SDS)。在整个分离过程中,使用抑制植物血凝素(PHA)刺激正常淋巴细胞作为抑制功能的指标来鉴定这些因子。通过这些技术,抑制活性被证明与含有N-乙酰-β-D-葡萄糖胺(NAcGlu)且分子量约为140,000和超过200,000道尔顿的糖蛋白相关。在PAGE-SDS上观察到另一个分子量为70,000道尔顿的小峰。各组分的pI值分别为7.4和4.2。该活性被加热、低pH值和反复冻融破坏,但对蛋白酶、脱氧核糖核酸酶、核糖核酸酶和神经氨酸酶具有抗性。活性组分与蛋白水解活性无关,并且促有丝分裂反应的抑制本质上是不可逆的。这些结果构成了在生物体液中检测该因子并进一步评估其在肿瘤与宿主关系中作用的研究基础。